David Wolinsky, MD FACC MASNC
DAVID WOLINSKY MD FACC MASNC SHORT BIO
Dr. Wolinsky joined the staff at Cleveland Clinic Florida in 2011. He was Section Head of Nuclear Cardiology until 2024 v More recently; he developed the cardiac amyloid clinic for which he is now Emeritus Director
David Wolinsky, MD is a graduate of Columbia University where he received his undergraduate and medical degrees. He carried out his postgraduate training and was on staff at St. Luke's Hospital in New York before joining Albany Associates in Cardiology where he worked as director of the nuclear cardiology program, which he founded, and also served as director of the heart failure and cardiac rehabilitation programs.
Dr. Wolinsky is a founding member of the American Society of Nuclear Cardiology. He was past-President of ASNC (2015) He was chair of the task force that developed Refer Wisely,a joint initiative of the American Society of Nuclear Cardiology and the American College of Physicians to provide education regarding the appropriate use of diagnostic imaging with a specific focus on myocardial perfusion imaging.
Most recently Dr. Wolinsky has focused his clinical work on cardiac amyloidosis. He has established a multidisciplinary program for the management of amyloidosis that is managing over 333 patients. He is involved in early diagnosis, nuclear imaging, and treatment of the disease. Dr. Wolinsky developed the scintigraphic imaging program for cardiac amyloidosis and has helped multiple nuclear cardiology labs improve their testing. He has participated in multiple clinical trials. His present research js focused on the management of octogenarians with cardiac amyloidosis, identifying predictors of morbidity and mortality and optimizing individualized therapy .
Financial relationships
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:Bridge BioTopic:ATTR-CMDate added:07/24/2026Date updated:08/06/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:Bridg BioTopic:ATTR-CMDate added:07/24/2026Date updated:08/06/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:PfizerTopic:ATTR-CMDate added:07/24/2026Date updated:08/06/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:Astr ZenecaTopic:ATTR-CMDate added:07/24/2026Date updated:08/06/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:viz.aiTopic:ATTR-CMDate added:07/24/2026Date updated:08/06/2026

Facebook
X
LinkedIn
Forward